Total
0
Shares
Source: The Herb Clinic
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • The agreement will see The Herb Clinic refer medical cannabis patients to Ayurcann through a patient education agreement
  • Ayurcann will work with the patients to educate them on their available offerings and help them select appropriate products
  • The Herb Clinic has over 4000 patients registered and is comprised of compassionate and knowledgeable service providers
  • Ayurcann Holdings is a provider of customized post-harvest outsourcing solutions to licensed cannabis producers
  • Ayurcann Holdings Corp. (AYUR) is down 2.63 per cent, trading at C$0.185 per share at 10:15 am ET

Ayurcann Holdings (AYUR) has entered into a patient-referral agreement with The Herb Clinic.

The Herb Clinic has over 4000 patients registered and is comprised of compassionate and knowledgeable service providers who are defined by their ability to provide exceptional patient care. They help educate and integrate cannabis into the patient’s medical treatment plans and partner with medicinal cannabis providers such as Ayurcann, to ensure their patients are getting top-quality advice with exceptional value.

The agreement will see The Herb Clinic refer medical cannabis patients to Ayurcann through a patient education agreement. Ayurcann will work with the patients to educate them on their available offerings and help them select appropriate products.

Igal Sudman, CEO of Ayurcann commented on the partnership with The Herb Clinic.

“Working with the leaders in the industry is what we strive towards, being able to partner with and enhance cannabis education, provide the best possible value, national coverage, while expending our offerings for the best national and international brands for THC and CBD based products to patients is making Ayurcann a leader in the industry.” 

Ayurcann is focused on becoming the partner of choice for Canadian cannabis brands by providing best-in-class, proprietary services including ethanol extraction, formulation, product development and custom manufacturing.

Ayurcann Holdings Corp. (AYUR) is down 2.63 per cent, trading at C$0.185 per share at 10:15 am ET.

More From The Market Herald

" Choom (CSE:CHOO) reports a profitable first quarter of 2022

Choom (CHOO) has announced results for Q1 2022 highlighted by net income of C$5.07M.

" Nextleaf (CSE:OILS) continuing to expand Glacial Gold brand

Nextleaf Solutions (OILS) announced its Glacial Gold brand of cannabis has been picked up by additional provincial distribution authorities.

" Simply Better Brands (TSXV:SBBC) announces third quarter 2021 results

Simply Better Brands (SBBC) experienced year-over-year growth this quarter, with higher revenue and gross margin compared to Q3 2020.

" Nabis Holdings (CSE:NAB) noteholders approve plan for the repurchase and de-listing of notes

Nabis Holdings (NAB) announces that 100 per cent of votes cast were in favour of the previously announced repurchase of all notes.